HPLC-MS/MS based Cytochrome P450 2C8 (CYP2C8) Inhibition Assessment Service

Creative Biolabs hereby launches the Cytochrome P450 2C8 (CYP2C8) Inhibition Assessment Service based on HPLC-MS/MS technology, which provides a comprehensive and accurate method to assess the potential inhibition of CYP2C8 enzymes by compounds. By leveraging state-of-the-art technology and expertise, we provide valuable insights into the potential of drug metabolism, pharmacokinetics, and drug-drug interactions. Our services are designed to support drug development efforts and ensure the safety and efficacy of pharmaceutical compounds. Based on our HPLC-MS/MS platform for CYP inhibition assessment, we provide you with a wide range of cytochrome P450 inhibition assays.

HPLC-MS/MS-based CYP Inhibition Assessment Platform

Fig.1 Platform. (Creative Biolabs Original)

HPLC-MS/MS-based Cytochrome P450 2C8 (CYP2C8) Inhibition Assessment Service

CYP2C8

CYP2C8 is a gene that encodes for an enzyme known as cytochrome P450 2C8. This enzyme is responsible for metabolizing various drugs and xenobiotics in the body. CYP2C8 is primarily found in the liver and plays a crucial role in the metabolism of drugs such as paclitaxel, amiodarone, and repaglinide. Variations in the CYP2C8 gene can affect an individual's response to these medications and may influence their efficacy and potential side effects.

What We Do

Our HPLC-MS/MS-based CYP2C8 inhibition assessment service offers a reliable and sensitive method to determine the inhibitory effects of compounds on CYP2C8 activity. The assay utilizes a specific CYP2C8 substrate and a cocktail of probe substrates for multiple CYP enzymes, allowing for comprehensive assessment of potential drug interactions.

Assessment of the inhibitory effect of test compounds on the activity of the cytochrome P450 enzyme CYP2C8.
Measurement of the enzyme activity using HPLC-MS/MS.
Determination of the IC50 value, which represents the concentration of the test compound needed to inhibit 50% of the enzyme activity.
Analyze the final data results and evaluate the inhibitory potency of the test compounds.

Detailed Information of Our Service

CYP2C8 Information

Protein Name	Family	Sub Family	Uniprot Number	Gene Name
CYP2C8	CYP450	CYP2	P10632	CYP2C8
Gene ID	Gene Aliases	Organism
1558	CYPIIC8\|CPC8	Human

Assay Information

Service Type

Biochemical

Detection Method

HPLC-MS/MS

Incubation

10 min at 37°C

Service Sub Type

Enzymatic

Measured Response

Peak Area Response

Substrate

Amodiaquine

Key Features of Our Service

High sensitivity and specificity of HPLC-MS/MS detection for accurate measurement of CYP2C8 activity
Comprehensive assessment of CYP2C8 inhibition potential using multiple probe substrates
Customizable assay design to meet specific project needs
Data analysis and interpretation by experienced scientists
Rapid turnaround time to support drug development timelines

Cooperation With Creative Biolabs

Fig.3 Cooperation. (Creative Biolabs Original)

Contact Us

For more information about our HPLC-MS/MS-based cytochrome P450 2C8 (CYP2C8) inhibition assessment service or other questions, you can contact us directly for assistance. Our team of experts is available 24 hours a day to answer any questions you may have and tailor a strategy to you regarding the services we offer. Let us help you advance your drug discovery projects with confidence and precision. We also offer other in vitro ADME services, if you are interested, you can click the keywords for more information!

Download our brochure

Loading case studies...

Online Inquiry